Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience

We evaluated the clinical impact, in daily clinical practice, of sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) therapies in patients with type 2 diabetes. Data from 500 unselected consecutive patients were retrospectively analyzed. Only th...

Descripción completa

Detalles Bibliográficos
Autores principales: Piazzolla, Giuseppina, Vozza, Alfredo, Volpe, Sara, Bergamasco, Alessandro, Triggiani, Vincenzo, Lisco, Giuseppe, Falconieri, Michela, Tortorella, Cosimo, Solfrizzi, Vincenzo, Sabbà, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263895/
https://www.ncbi.nlm.nih.gov/pubmed/35859794
http://dx.doi.org/10.1515/med-2022-0504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263895/
https://www.ncbi.nlm.nih.gov/pubmed/35859794
http://dx.doi.org/10.1515/med-2022-0504

Ejemplares similares